FDA human clinical studies
This article was originally published in The Tan Sheet
Executive Summary
Division of Scientific Investigations Director David Lepay, MD/PhD, named DSI senior adviser for clinical science. Lepay will oversee human clinical studies policy in his role in the newly created position. Reporting to acting Senior Adviser for Science Elizabeth Jacobson, PhD, Lepay will oversee the creation of an Office of Clinical Science within the Office of Science Coordination & Communication
You may also be interested in...
FDA Office For Good Clinical Practice To Oversee Research Protections
FDA's Office for Good Clinical Practice will oversee the agency's human subject protection and data integrity efforts
FDA Office For Good Clinical Practice To Oversee Research Protections
FDA's Office for Good Clinical Practice will oversee the agency's human subject protection and data integrity efforts
FDA Office For Good Clinical Practice To Oversee Research Protections
FDA's Office for Good Clinical Practice will oversee the agency's human subject protection and data integrity efforts